Stanford University
Showing 27,901-27,920 of 35,031 Results
-
Siddu Shivanagoudra
Postdoctoral Scholar, Gastroenterology
BioSiddu Shivanagoudra is a postdoctoral scholar in the Spencer Lab investigating how gut microbiota-derived metabolites modulate intestinal immune signaling and barrier function. He holds an MS in Horticultural Sciences and a PhD in Biomedical Engineering from Texas A&M University. His work spans tryptophan metabolite biology, AHR/GPR35 signaling, and defined bacterial consortia, integrating cellular, transcriptomic, and metabolomic approaches. Siddu aims to translate these mechanistic insights into microbiome-targeted therapeutic strategies for inflammatory gut diseases.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
Yoav Shoham
Professor of Computer Science, Emeritus
BioYoav Shoham is professor emeritus of computer science at Stanford University. A leading AI expert, Prof. Shoham is Fellow of AAAI, ACM and the Game Theory Society. Among his awards are the IJCAI Research Excellence Award, the AAAI/ACM Allen Newell Award, and the ACM/SIGAI Autonomous Agents Research Award. His online Game Theory course has been watched by close to a million people. Prof. Shoham has founded several AI companies, including TradingDynamics (acquired by Ariba), Katango and Timeful (both acquired by Google), and AI21 Labs. Prof. Shoham also chairs the AI Index initiative (www.AIindex.org), which tracks global AI activity and progress, and WeCode (www.wecode.org.il), a nonprofit initiative to train high-quality programmers from disadvantaged populations.
